Eko Foundation Analysis Software with Transformers (EFAST) vs ZEUS System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by iRhythm Technologies

AI Verdict

EFAST by Eko Health is designed for real-time, point-of-care detection of structural murmurs and atrial fibrillation during routine auscultation with a digital stethoscope. In contrast, the ZEUS System by iRhythm Technologies focuses on long-term continuous ECG monitoring via wearable biosensors to detect and characterize various arrhythmias, including AFib, over an extended period. Therefore, EFAST is suited for immediate screening in clinical settings, while ZEUS is better for prolonged diagnostic monitoring of suspected or known arrhythmias.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, immediate cardiac insight during a routine physical examination. This tool excels at providing AI-powered detection of structural murmurs and atrial fibrillation directly during auscultation, enabling prompt clinical decision-making at the point of care.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose ZEUS System if…

Choose the ZEUS System if you require long-term, continuous cardiac monitoring to detect and characterize intermittent or asymptomatic arrhythmias. This system is ideal for capturing events over an extended period (up to 14 days) using wearable biosensors, providing comprehensive data for arrhythmia diagnosis and management that might be missed in a single office visit.

View ZEUS System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) ZEUS System
Pricing Subscription-based, contact for details Not disclosed
Deployment Cloud-based Software as a Medical Device (SaMD) Cloud-based (AWS EC2 platform), no on-premise hardware.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST integrates seamlessly into a clinician's real-time workflow during auscultation, offering immediate AI analysis, enhanced audio, and waveform visualization directly through digital stethoscopes. The associated Eko CORE 500 stethoscope has received a Red Dot Design Award for its intuitive user experience and seamless integration. While ZEUS focuses on patient-worn devices for long-term monitoring, EFAST's point-of-care integration provides more immediate clinical utility.

Clinical Value

Eko Foundation Analysis Software with Transformers (EFAST)

Both tools offer significant clinical value with FDA clearances and high accuracy. EFAST provides real-time detection of structural murmurs (93% sensitivity, 91% specificity), atrial fibrillation (95% sensitivity, 94% specificity), and low ejection fraction at the point of care. This broad, immediate diagnostic capability during routine exams gives it a slight edge over ZEUS's focus on long-term arrhythmia monitoring, despite ZEUS's high accuracy for AFib detection and overall diagnostic yield.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A (EFAST) offers more transparency regarding its pricing model, stating it is subscription-based with an annual Eko+ membership and an approximate daily cost for its associated stethoscope technology. In contrast, Tool B (ZEUS System) provides no disclosed pricing information, making it challenging to assess its value proposition without direct inquiry.

Enterprise Readiness

ZEUS System

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and offer EMR/EHR integration. However, Tool B (ZEUS System) has a notable strategic partnership with Epic, a leading EHR provider, utilizing Epic's Aura platform to significantly streamline integration processes and expand access to its services for a vast number of healthcare organizations and patients. This deep, explicit integration with a major EHR platform demonstrates superior enterprise readiness.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST is highlighted as the 'first FDA-cleared foundation model for cardiovascular AI' and leverages 'Transformers' architecture, integrating advanced AI into the traditional stethoscope workflow for real-time insights. This represents a cutting-edge application of AI technology at the point of care. While ZEUS also utilizes deep-learned algorithms for long-term monitoring, EFAST's specific mention of a foundation model and real-time integration into a traditional exam tool signifies a potentially more disruptive innovation.

Support & Docs

ZEUS System

Tool B (ZEUS System) explicitly offers 24/7 patient support via phone and email, alongside dedicated project management and ongoing post-implementation support for healthcare professionals integrating their services. Tool A (EFAST) provides a help center, user manuals, and options to schedule calls or submit tickets, but does not specify 24/7 availability for general support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) ZEUS System
Product Name Eko Foundation Analysis Software with Transformers (EFAST) ZEUS System
Company Eko Health iRhythm Technologies
Description EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. The ZEUS System by iRhythm Technologies is an AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation.
Key AI Detections AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity) AI-powered arrhythmia detection; Detection and characterization of Atrial Fibrillation (AFib)
EMR/EHR Integration EMR integration for streamlined documentation HL7-based EHR integration
Associated Hardware/Sensors Seamless integration with Eko digital stethoscopes (e.g., CORE 500) Integration with Zio Watch and Zio monitors
Continuous Monitoring Duration Not specified Continuous ECG monitoring (up to 14 days)

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and ZEUS System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation (AFib) in real-time during routine exams. In contrast, the ZEUS System by iRhythm Technologies focuses on long-term continuous cardiac monitoring to aid in the detection and characterization of various arrhythmias, including AFib, for both symptomatic and asymptomatic cardiac events.
EFAST integrates with Eko digital stethoscopes, such as the CORE 500, to provide real-time AI analysis during auscultation. The ZEUS System, on the other hand, analyzes ECG data from wearable biosensors like the Zio Watch and Zio monitors for continuous cardiac monitoring.
EFAST is designed for AI-powered detection of structural murmurs and atrial fibrillation, with reported sensitivities of 93% and 95% respectively, and specificities of 91% and 94%. The ZEUS System is designed for AI-powered arrhythmia detection, including the detection and characterization of Atrial Fibrillation, through continuous ECG monitoring for up to 14 days.
EFAST provides real-time AI analysis during the auscultation portion of a routine exam. The ZEUS System offers long-term continuous ECG monitoring for up to 14 days.
EFAST offers EMR integration for streamlined documentation of cloud-based recordings and secure storage of exams. The ZEUS System supports HL7-based EHR integration.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.